Our Mission
Since 2010, we have empowered individuals with advanced home-use photobiomodulation (PBM) technology while driving scientific breakthroughs in brain health and beyond.
Over a decade ago, we invented transcranial brain photobiomodulation (tPBM) and intranasal photobiomodulation (iPBM). Our intranasal-transcranial brain PBM (itPBM) technology, the Vielight Neuro, has demonstrated efficacy in the most independent PBM clinical trials for challenging conditions, with over 500 clinical trial participants in published clinical trials to date.
As the original inventors of brain photobiomodulation, we lead the industry with the largest utility patent portfolio, from Artificial Intelligence (AI)-based neuromodulation, to intranasal-transcranial brain and vagus nerve photobiomodulation.
Guided by a deep commitment to collaboration, we work alongside leading researchers and clinicians worldwide. Our core team brings together neuroscientists, medical doctors and photonics engineers, blending scientific rigor with engineering innovation.
Vielight Inc. is FDA registered as a medical device establishment. Our manufacturing and quality systems are built to meet international quality management standards, certified to ISO 13485:2016 and MDSAP standards.
Our dedication to research
Attaining our goal of helping people through photobiomodulation would not be possible without the right people. That is why Vielight have gathered many bright minds from a diverse range of scientific backgrounds to continuously improve the efficacy of brain and systemic photobiomodulation technology.
Vieclinic | Psychiatry Center
Vieclinic is our brain intervention & psychiatry center in Toronto, combining psychiatry, medical neurology and neurotechnology. Our years of experience and research in the field of brain stimulation has enabled us to form Vieclinic with leading minds dedicated to healing and enhancing human minds.
Management
Lew Lim
Founder & CEO
Dr Lew Lim is widely recognized as an expert on photobiomodulation (PBM), particularly in its application for brain functions and the effect on the immune system. He owns the largest number of worldwide issued and pending patents related to PBM as an individual. He is member of the Forbes Technology Council.
Glynn Jones
Chief Financial Officer
Glynn is a Chartered Professional Accountant who trained at Ernst & Whinney and KPMG, and has many years experience in public practice and in senior financial positions at private and public companies, as well as in the University and non-profit sectors in British Columbia. He moved to Toronto and joined Vielight in 2013.
Peter Adams
VP, Business Development
Peter has worked in executive, consulting and management positions both internationally and in Canada, in large corporations and startups. He has also worked as a consultant at Fortune 500 companies. His current focus is on early-market development for Vielight Inc.
Vielight Research Division
Dr. Lew Lim
Founder & CEO
Dr Lew Lim, PhD, MBA, DNM, FCMA, CA(M), Grad Cert (Eng) is a Doctor of Natural Medicine, with graduate degrees, diplomas, certifications and professional credentials in engineering, neuroscience, business and accountancy. He obtained these from the University of California, Berkeley, Sheffield University, Duke University, Quantum University, Chartered Institute of Management Accountants (UK) and others.
He is widely recognized as an expert on photobiomodulation (PBM), particularly in its application for brain functions and the effect on the immune system. He owns the largest number of worldwide issued and pending patents related to PBM as an individual.
Dr. Marzieh Zare
AI Research and Scientist
Dr Marzieh Zare, Ph.D Physics has over a decade of experience in AI/ML. She earned her PhD from the University of North Texas.
Marzieh’s work lives at the intersection of intelligence of human and machine. She began her journey in academia, studying the brain as a complex system.
In 2023, she was honored with the Woman in AI award, selected as one of the top 20 AI innovators of the year in North America.
Dr. Nazanin Hosseinkhah
Research Manager and Physicist
Nazanin has a MSc in Physics and a PhD in Medical Biophysics from University of Toronto, located at Sunnybrook Hospital
Naz manages brain imaging research projects with photobiomodulation in collaboration with major research organizations, such as the University of Alberta and Baycrest Hospital.
Given her background in biophysics, Naz’s passion aligns with Vielight’s goal of discovering how light energy could be used optimally to positively impact human physiology.
Dr. Genane Loheswaran
Research Manager and Neuroscientist
Genane holds a MSc in Neuroscience from McMaster University and a PhD in Pharmacology from the University of Toronto.
Gena manages Vielight’s research projects with various organizations for cognitive science, such as combining photobiomodulation with EEG.
Gena is passionate about neuroscience and a strong believer in the potential of photobiomodulation for improving mental acuity and Brain wellness.
Dr. Janine Liburd
Clinical Trial Manager and Scientist
Janine holds a PhD in Biochemistry from Queens University, Ontario. Janine has been a part of Vielight since its founding.
Presently, she manages and handles Vielight’s pivotal Alzheimer’s disease clinical trial – including protocol planning, recruitment and operations.
Janine utilizes her decade-long experience in the field of photobiomodulation to help further discoveries.
Parnian Puramat
Research Coordinator
Parnian holds a Master of Health Science in Translational Research from the University of Toronto and a BSc in Pharmacology.
At Vielight, she supports the design and coordination of clinical studies exploring the effects of photobiomodulation on mental health and cognitive performance.
Her interdisciplinary background in pharmacology, neuroscience, and clinical research supports a passion for translating scientific insights into accessible, real-world solutions.
Shenoa Ragavaloo
Research Coordinator
Shenoa holds a Master’s degree in Psychology specialized in Neuroscience from York University.
At Vielight, Shenoa works in clinical and experimental studies using photobiomodulation. Her interdisciplinary background in neuroscience, product development and research management supports the advancement of brain-focused technologies that enhance human health and performance.
Shenoa is dedicated to bridging science and real-world impact through innovative brain, wellness and neurotechnology research and product development.
Dr. Mahroo Karimpoor
Research Scientist
Mahroo has a MSc in Tissue Engineering and Biomaterial Sciences and a PhD in Pharmaceutical and Biomaterial Science from University College London in the UK.
Mahroo is investigating the potential beneficial effects of photobiomodulation in elderly cognition and brain aging. She also researches the effects of photobiomodulation on neuro-oscillations.
Janine utilizes her decade-long experience in the field of photobiomodulation to help further discoveries.
Vieclinic Psychiatry Division
Dr. Danilo de Jesus
Psychiatrist
Dr. Danilo de Jesus is a psychiatrist who specializes in mood and psychotic disorders, and brain stimulation treatments. He has completed his medical education and residency in Psychiatry in Brazil, a Master’s degree in schizophrenia and fellowships in Brain Stimulation and Complex Mental Illness at the University of Toronto.
He worked at CAMH until 2019, then moved to Queen’s University, leading an acute inpatient unit. He currently focuses on community and interventional psychiatry at Providence Care Hospital. His research mainly focuses on brain stimulation modalities such as rTMS and PBM in psychiatry.
Dr. Jeané Viljoen
Psychiatrist
Dr. Jeané Viljoen earned her Bachelor of Science at the University of Calgary and her BM BS medical degree from the University of Limerick, Ireland. She completed her psychiatry residency at the University of Toronto and has been practicing in the GTA and Halton regions since 2018. Her areas of interest include primary psychotic disorders, mood disorders, first-episode psychosis, and electroconvulsive therapy (ECT).
Dr. Seyed-Mohammad Fereshtehnejad
Neurologist
Dr. Fereshtehnejad serves as a Neurologist and Movement Disorders Clinical Fellow at Toronto Western Hospital, University of Toronto. He holds an MD degree and has completed master’s programs in Public Health and Medical Education in Tehran, Iran. He further earned a PhD in Clinical Neuroscience and Neuroepidemiology from Karolinska Institutet in Stockholm, Sweden. His current research primarily focuses on the prodromal stage and progression biomarkers of Parkinson’s disease (PD).
Dr. Minella de Souza
Neuropsychiatrist
Dr. Minella de Souza completed her Neuropsychiatry Fellowship at the University of Toronto in 2005, working at Toronto Western Hospital and Bloorview Macmillan Children’s Rehabilitation Hospital. She later transitioned to private practice to explore interests in QEEG, biofeedback, and neuromodulation.
Andjelka Palikucin
Clinical Psychologist
Andjelka is a registered Clinical Psychologist who has been serving the Toronto community since 2007. Over the past two decades, she has worked extensively with adults navigating challenges related to anxiety, depression, and trauma. Her clinical approach is compassionate, evidence-based, and tailored to each individual’s needs.
Megan Kaiser
Brain Intervention Technician
Megan earned her Bachelor of Science specializing in Biology and Psychology from Queen’s University. She is an experienced technician skilled in delivering a variety of neuromodulation treatments. Megan applies her technical expertise and background in biopsychology to ensure safe and effective patient care.
Bing Jie (Jessica) Li
Clinical Practice Support Executive
With a Master of Nursing from the University of Toronto, Jessica brings a vast array of experience in mental health care, administration, and research. She served six years as a Mental Health Clinician with Mount Sinai Hospital’s ACT Team, supporting individuals with severe schizophrenia, bipolar disorder, depression, and other mood disorders, and also has experience working with children with autism in a private school setting. She has also contributed to research and mental health initiatives at the University Health Network.
Independent Research Collaborators
Dr. Elisabeth Wilde, PhD
Neurologist and Health Scientist
Dr. Elisabeth Wilde is an Associate Professor in the Department of Neurology at the University of Utah. She also holds an appointment as a Health Research Scientist at the VA Salt Lake City Healthcare System.
She was a primary researcher in a groundbreaking n=49 TBI study, conducted at the University of Utah with ex-footballers, using the Vielight Neuro Gamma. The study is pending publication.
Dr. Jack Tuszynski
Computational Biophysicist
Dr. Tuszynski is a Fellow of the National Institute for Nanotechnology of Canada. He is an Allard Chair and Professor in Experimental Oncology in the Department of Oncology at the University of Alberta’s Cross Cancer Institute and a Professor in the Department of Physics.
His research conducted with the Vielight Neuro Alpha provides a deeper level of understanding of the way living cells, cellular structures, and components such as microtubules respond to NIR photobiomodulation.
Dr. Michael Hamblin
Researcher
Prof M.R. Hamblin (Ph.D.) was the Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, an Associate Professor of Dermatology at Harvard Medical School and is a member of the affiliated faculty of the Harvard-MIT Division of Health Science and Technology.
Dr. Hamblin co-authored the world’s first published study suggesting efficacy for brain photobiomodulation for Alzheimer’s Disease. The study featured Vielight Neuro technology.
Dr. Reza Zomorrodi
Neuroscientist and EEG Researcher
Dr. Reza Zomorrodi has a PhD in Nuclear Physics and a PhD in Computational Neuroscience from Université Laval in Quebec.
Dr. Zomorrodi was the first in the world to publish a scientific paper showing the neuromodulatory effects of NIR light energy on the brain. The study used the Vielight Neuro Gamma. To date, the Vielight Neuro Gamma is the only commercially available brain photobiomodulation device to demonstrate neuromodulatory effects in a peer-reviewed published study in a high level journal.
Dr. Linda Chao
Neuroscientist and Radiologist
Linda Chao, PhD, is a Professor in the Department of Radiology and Biomedical Imaging and in the Department of Psychiatry at the University of California, San Francisco. Dr. Chao obtained her BS in Biological Science from the University of California, Davis in 1991, and she completed her PhD studies in Neuroscience from UCD in 1996. For the past 11-years, she has served as leader for the Psychiatry Block.
Dr. Chao was the first to successfully combine fMRI imaging with brain photobiomodulation research to evidence neurophysiological changes in Alzheimer’s patients. She used the Vielight Neuro in her studies.
Dr. David Tate
Neuropsychologist
Dr. David Tate is a clinical neuropsychologist trained at Brigham Young University and Brown Medical School. He is heavily involved in medical imaging research used to examine a number of developmental, clinical, and medical disorders including traumatic brain injury.
Dr. Tate was a primary researcher in a groundbreaking n=49 TBI study, conducted at the University of Utah with ex-footballers, using the Vielight Neuro Gamma. The study is pending publication.
Dr. Neda Rashidi-Ranjbar, MD
Medical Monitor
Dr. Neda Rashidi-Ranjbar a Clinician Scientist holding both an MD and a PhD, currently serves as a postdoctoral fellow at St. Michael’s Hospital. She earned her doctoral degree in medical science from the University of Toronto. At present, Dr. Nana is at the forefront of pioneering research focused on the application of photobiomodulation (PBM) for the treatment of Mild Cognitive Impairment (MCI).
Dr. Larry Carr
Researcher
Dr. Larry Carr is a former BYU graduate and BYU Hall of Fame Football player. He received a Ph.D. from BYU in exercise physiology and taught at the university level until CTE-like symptoms forced him to step down.
Dr. Carr was enrolled in a CTE-study by Dr. Naeser and was inspired by the Vielight Neuro’s ability to greatly improve his CTE-symptoms, bringing him back to baseline. As such, he now leads several research initiatives for brain photobiomodulation, TBI and CTE at the U of Utah.
Dr. Jean Chen
Neuroscientist and EEG Researcher
Dr. Chen received her MSc (2004) in Electrical Engineering from the University of Calgary, and her PhD (2009) in Biomedical Engineering from McGill University. She completed her postdoctoral work on multimodal MRI of brain aging at Harvard Medical School (2011). She is a Senior Scientist at the Rotman Research Institute and Tier II Canada Research Chair in Neuroimaging of Aging.
Dr. Chen is conducting fMRI-based studies with Vielight technology on the brain, to help discover optimal brain photobiomodulation parameters.
Dr. Javier Peña
Researcher
Dr. Javier Peña currently works at the Faculty of Psychology and Education, University of Deusto. Javier does research in Neuropsychology, Abnormal Psychology, Clinical Psychology and creativity. Their current project is ‘Neurocrea Project’.
Dr. Peña co-authored the first published study linking brain photobiomodulation to improved creativity. The study featured Vielight Neuro technology.
Dr. Margaret Naeser
Neurologist and VA Health Scientist
Dr. Margaret Naeser is Research Professor of Neurology, Boston University School of Medicine and Research Linguist/Speech-Language Pathologist, V.A. Boston Healthcare System.
Dr. Naeser has published multiple TBI and CTE studies using Vielight Neuro technology on US Army Veterans.
Marketing and Analytics Division
Dominic Jake King Lim
Director, IT and Marketing
Dominic graduated with a HBSc. Computational Mathematics from Wilfrid Laurier University.
He is involved in company operations, spanning from facilitating operational plans, strategic initiatives, part-time web development and social media engagement.
Scott Pidgeon
Senior Manager, Business Development
Scott has a BSc in Kinesiology from Brock University.
Scott is an accomplished business development leader and wellness advocate uniquely positioned at the intersection of neuroscience, technology, and human performance.
Maya Okamoto
Medical Device Development
Maya has a HBSc. Pharmacology and Biochemistry from the University of Toronto.
She applies her expertise to drive Vielight’s growth through effective marketing and sales initiatives while building meaningful relationships with partners, clinicians, and customers.
Peter Kusiak
Sports Manager and Regulatory Associate
Peter has a HBSc from University of Toronto.
Peter is involved in sports market development and works with product and quality teams to address regulatory projects.
Amy Zhang
Quality System and Projects Engineer
Amy holds a Master’s degree in Mechanical Engineering from the University of Saskatchewan, Canada.
She is a licensed professional engineer with over a decade of experience in mechanical engineering. Her expertise lies in project coordination and management, regulatory documentation, mechanical engineering design, mechanical property testing, and stress/fatigue analysis through FEA.
Payal Khanwani
Senior Program Manager
Payal holds a MSCc in Biomedical Engineering from Universität zu Lübeck, Switzerland.
Payal drives partnerships and collaborations with alternative health practitioners, researchers, companies, wellness and longevity leaders, bringing neuroscience-based tools to the forefront of peak performance, recovery, and conscious well-being.
Rico Petrini
Sports Performance Consultant
Rico Petrini holds a specialty dual major from Oregon State University in Business Administration and Communications. While at Oregon State, Rico also was a 4-year starter on the Football team, an ALL-League selection at Linebacker, and Team MVP.
Rico’s primary passion is an interest in neuro-tech studies, research, and performance. His responsibilities at Vielight include matching our extensive line of products with the best solution to maximize potential in sports, cognitive support, or optimal systemic wellness & recovery.
Liyao Ji
Manager, Quality and Regulatory Affairs
Liyao is the Manager, Quality and Regulatory Affairs at Vielight. She takes the lead in quality assurance and regulatory projects. She has a MSc in Biotechnology from McGill University.
Liyao is a certified Regulatory Affairs professional and holds the Regulatory Affairs Certificate (RAC-Device) issued by Regulatory Affairs Professional Society (RAPS).
